FDA Import Refusal SCS-9466513-1/11/1 — Aristo Pharma Gmbh
The FDA refused shipment SCS-9466513-1/11/1 from Aristo Pharma Gmbh (Germany) on May 7, 2020. The refused product falls under Drugs and Biologics — HYDROXYCHLOROQUINE SULFATE (ANTI-PROTOZOAL, A-LEISHMANIAL, A-MALARIAL). Cited charges: 118,3280 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- May 7, 2020
- Country
- Germany
- Product Category
- Drugs and Biologics
- Product Code
- 62LCY29 HYDROXYCHLOROQUINE SULFATE (ANTI-PROTOZOAL, A-LEISHMANIAL, A-MALARIAL)
- Charges
- 118,3280